Literature DB >> 33363608

Perspectives on skin disorder diagnosis among people living with HIV in southeastern Romania.

Miruna Draganescu1, Liliana Baroiu1, Alina Iancu2, Caterina Dumitru3, Diana Radaschin1, Eduard Drima Polea1, Carmen Bobeica4, Alin Laurentiu Tatu1, Elena Niculet2, Gyula Laszlo Fekete5.   

Abstract

The beginnings of the human immunodeficiency virus (HIV) pandemic are closely linked to dermatological conditions. A large part of the population living with HIV (PLWH) has a series of skin conditions that determine at some point, a visit to the dermatologist. The introduction of highly active antiretroviral therapy (HAART) more than 20 years ago has diminished the range of dermatological conditions, with improved immunosuppression of CD4 lymphocytes. The study aimed to describe the prevalence of the diagnosed type of skin changes in PLWH receiving antiretroviral therapy and their stratification according to the degree of immunodeficiency. A prospective study was conducted on 57 PLWH evaluated monthly at an HIV outpatient clinic, from a tertiary hospital in southeastern Romania. Clinical examination and dermoscopy revealed the existence of a wide range of dermatological conditions; all 57 patients (100%) being diagnosed with one or more dermatological conditions. As our study shows, the prevalence of different dermatoses among PLWH varies depending on the geographical region. At the same time, under HAART, the image of dermatoses associated with decreased immunity from HIV infection has changed. The skin changes of PLWH no longer fully follow the classical staging, based on the degree of immunosuppression.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  HIV status; dermoscopy; diagnosis; immunodeficiency; skin disorders

Year:  2020        PMID: 33363608      PMCID: PMC7725011          DOI: 10.3892/etm.2020.9529

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  5 in total

1.  Some Manifestations of Tuberculosis in Otorhinolaryngology - Case Series and a Short Review of Related Data from South-Eastern Europe.

Authors:  Adela-Ioana Mocanu; Cosmin Moldovan; Ioana Soare; Alin Laurentiu Tatu; Claudiu Ionut Vasile; Paraschiva A Postolache; Horia Mocanu; Elena Niculet; Daniela Diculencu; Alexandru Nechifor
Journal:  Infect Drug Resist       Date:  2022-05-31       Impact factor: 4.177

2.  CREST Syndrome in Systemic Sclerosis Patients - Is Dystrophic Calcinosis a Key Element to a Positive Diagnosis?

Authors:  Carmen Bobeica; Elena-Laura Parapiru; Carmina Liana Musat; Ciprian Dinu; Iulia Chiscop; Luiza Nechita; Mihaela Debita; Victorita Stefanescu; Ioana Anca Stefanopol; Alexandru Nechifor; Ana Maria Pelin; Gabriela Balan; Silvia Chirobocea; Claudiu Ionut Vasile; Elena Niculet; Mihaela Craescu; Alin Laurentiu Tatu
Journal:  J Inflamm Res       Date:  2022-06-09

Review 3.  Basal cell carcinoma: Comprehensive clinical and histopathological aspects, novel imaging tools and therapeutic approaches (Review).

Authors:  Elena Niculet; Mihaela Craescu; Laura Rebegea; Carmen Bobeica; Florentina Nastase; Gabriela Lupasteanu; Daniela Jicman Stan; Valentin Chioncel; Lucretia Anghel; Mihaela Lungu; Alin Laurentiu Tatu
Journal:  Exp Ther Med       Date:  2021-11-18       Impact factor: 2.447

4.  Prevalence of Antibiotic Resistance of ESKAPE Pathogens Over Five Years in an Infectious Diseases Hospital from South-East of Romania.

Authors:  Manuela Arbune; Gabriela Gurau; Elena Niculet; Alina Viorica Iancu; Silvia Fotea; Gabriela Lupasteanu; Mihaela Camelia Vasile; Alin Laurentiu Tatu
Journal:  Infect Drug Resist       Date:  2021-06-24       Impact factor: 4.003

Review 5.  Nasopharyngeal carcinoma: A new synthesis of literature data (Review).

Authors:  Daniela Jicman Stan; Elena Niculet; Mihaela Lungu; Cristian Onisor; Laura Rebegea; Doinita Vesa; Laura Bezman; Florin Ciprian Bujoreanu; Mihaela Ionela Sarbu; Raul Mihailov; Silvia Fotea; Alin Laurentiu Tatu
Journal:  Exp Ther Med       Date:  2021-12-13       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.